Intellia Therapeutics
NTLA
NTLA
299 hedge funds and large institutions have $3.42B invested in Intellia Therapeutics in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 119 increasing their positions, 93 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $4.69B → $3.42B (-$1.27B)
35% less call options, than puts
Call options by funds: $31.9M | Put options by funds: $49M
66% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 67
Holders
299
Holding in Top 10
6
Calls
$31.9M
Puts
$49M
Top Buyers
| 1 | +$40.6M | |
| 2 | +$37.9M | |
| 3 | +$37.3M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$27.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.9M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$25.4M | |
| 3 | -$22.5M | |
| 4 |
DVF
Discovery Value Fund
Singapore
|
-$20.4M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$17.5M |